BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31573954)

  • 1.
    Xu H; Zhao X; Bhojwani D; E S; Goodings C; Zhang H; Seibel NL; Yang W; Li C; Carroll WL; Evans WE; Yang JJ
    Clin Cancer Res; 2020 Jan; 26(1):256-264. PubMed ID: 31573954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of ARID5B gene variants with acute lymphoblastic leukemia in Yemeni children.
    Al-Absi B; Noor SM; Saif-Ali R; Salem SD; Ahmed RH; Razif MF; Muniandy S
    Tumour Biol; 2017 Apr; 39(4):1010428317697573. PubMed ID: 28381164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
    Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
    Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
    Xu H; Cheng C; Devidas M; Pei D; Fan Y; Yang W; Neale G; Scheet P; Burchard EG; Torgerson DG; Eng C; Dean M; Antillon F; Winick NJ; Martin PL; Willman CL; Camitta BM; Reaman GH; Carroll WL; Loh M; Evans WE; Pui CH; Hunger SP; Relling MV; Yang JJ
    J Clin Oncol; 2012 Mar; 30(7):751-7. PubMed ID: 22291082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia.
    Zhao X; Qian M; Goodings C; Zhang Y; Yang W; Wang P; Xu B; Tian C; Pui CH; Hunger SP; Raetz EA; Devidas M; Relling MV; Loh ML; Savic D; Li C; Yang JJ
    J Natl Cancer Inst; 2022 Sep; 114(9):1287-1295. PubMed ID: 35575404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan.
    Lin CY; Li MJ; Chang JG; Liu SC; Weng T; Wu KH; Yang SF; Huang FK; Lo WY; Peng CT
    Blood Cells Mol Dis; 2014; 52(2-3):140-5. PubMed ID: 24200646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research advances on correlation of ARID5B gene with childhood acute lymphoblastic leukemia - review].
    Qian XF; Yang GH; Yin CY; Chen X; Shen YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1280-3. PubMed ID: 23114164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutional and acquired genetic variants in ARID5B in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ragnarsson C; Yang M; Moura-Castro LH; Aydın E; Gunnarsson R; Olsson-Arvidsson L; Lilljebjörn H; Fioretos T; Duployez N; Zaliova M; Zuna J; Castor A; Johansson B; Paulsson K
    Genes Chromosomes Cancer; 2024 May; 63(5):e23242. PubMed ID: 38738968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
    Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL
    Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia.
    Ebinger S; Özdemir EZ; Ziegenhain C; Tiedt S; Castro Alves C; Grunert M; Dworzak M; Lutz C; Turati VA; Enver T; Horny HP; Sotlar K; Parekh S; Spiekermann K; Hiddemann W; Schepers A; Polzer B; Kirsch S; Hoffmann M; Knapp B; Hasenauer J; Pfeifer H; Panzer-Grümayer R; Enard W; Gires O; Jeremias I
    Cancer Cell; 2016 Dec; 30(6):849-862. PubMed ID: 27916615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.
    Bekker-Méndez VC; Núñez-Enríquez JC; Torres Escalante JL; Alvarez-Olmos E; González-Montalvoc PM; Jiménez-Hernández E; Sansón AM; Leal YA; Ramos-Cervantes MT; Guerra-Castillo FX; Ortiz-Maganda MP; Flores-Lujano J; Pérez-Saldivar ML; Velazquez-Aviña MM; Bolea-Murga V; Torres-Nava JR; Amador-Sanchez R; Solis-Labastida KA; Rámirez-Bello J; Fragoso JM; Mejía-Aranguré JM;
    Arch Med Res; 2016 Nov; 47(8):623-628. PubMed ID: 28476190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility.
    Gutiérrez-Camino Á; López-López E; Martín-Guerrero I; Sánchez-Toledo J; García de Andoin N; Carboné Bañeres A; García-Miguel P; Navajas A; García-Orad Á
    J Cancer Res Clin Oncol; 2013 Nov; 139(11):1879-86. PubMed ID: 24013273
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mosaad YM; Khashaba M; Darwish A; Darwish M; Elwassefy M; Abdelmabood S; Fawzy IM; Youssef LF; Elbasiouny RA
    Pediatr Hematol Oncol; 2019 Sep; 36(6):365-375. PubMed ID: 31424309
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
    Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
    Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family-based exome-wide association study of childhood acute lymphoblastic leukemia among Hispanics confirms role of ARID5B in susceptibility.
    Archer NP; Perez-Andreu V; Stoltze U; Scheurer ME; Wilkinson AV; Lin TN; Qian M; Goodings C; Swartz MD; Ranjit N; Rabin KR; Peckham-Gregory EC; Plon SE; de Alarcon PA; Zabriskie RC; Antillon-Klussmann F; Najera CR; Yang JJ; Lupo PJ
    PLoS One; 2017; 12(8):e0180488. PubMed ID: 28817678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of two ARID5B gene variant single nucleotide polymorphisms with acute lymphoblastic leukemia in the Egyptian population.
    Gamaleldin MA; Imbaby SAE
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):337-343. PubMed ID: 36708585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARID5B gene rs10821936 polymorphism is associated with childhood acute lymphoblastic leukemia: a meta-analysis based on 39,116 subjects.
    Guo LM; Xi JS; Ma Y; Shao L; Nie CL; Wang GJ
    Tumour Biol; 2014 Jan; 35(1):709-13. PubMed ID: 23975371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in ARID5B gene are associated with the development of acute lymphoblastic leukemia in Mexican children.
    Reyes-León A; Ramírez-Martínez M; Fernández-García D; Amaro-Muñoz D; Velázquez-Aragón JA; Salas-Labadía C; Zapata-Tarrés M; Velasco-Hidalgo L; López-Santiago N; López-Ruiz MI; Malavar-Guadarrama MA; Cárdenas-Cardós R; Paredes-Aguilera R; Rivera-Luna R; Dean M; Pérez-Vera P
    Ann Hematol; 2019 Oct; 98(10):2379-2388. PubMed ID: 31227872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
    Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.